{"nct_id":"NCT03496974","title":"A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic Dermatitis","status":"COMPLETED","status_verified_date":"2021-02","start_date":"2018-05-21","start_date_type":"ACTUAL","primary_completion_date":"2018-12-04","primary_completion_date_type":"ACTUAL","completion_date":"2018-12-11","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}